Cas:107430-92-2 3-(tert-Butyl)-4-methoxybenzaldehyde manufacturer & supplier

Chemical Name:3-(tert-Butyl)-4-methoxybenzaldehyde

CAS.NO:107430-92-2

Synonyms:3-tert-butyl-4-methoxybenzaldehyde;3-TERT-BUTYL-4-METHOXYBENZALDEHYDE

Molecular Formula:C₁₂H₁₆O₂

Molecular Weight:192.25400

HS Code:2912499000

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:26.30000

Exact Mass:192.11500

LogP:2.80520

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-tert-butyl-4-methoxybenzaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-TERT-BUTYL-4-METHOXYBENZALDEHYDE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-tert-butyl-4-methoxybenzaldehyde Use and application,3-TERT-BUTYL-4-METHOXYBENZALDEHYDE technical grade,usp/ep/jp grade.

Related News: Innova’s kit includes a nasal swab and a lateral flow test strip, which in less than a half-hour produces colored lines to display a positive reading, similar to a pregnancy test. However, the FDA said that false-negative and false-positive results may lead to delayed diagnoses, inappropriate treatment and the further spread of the virus. 3-(tert-Butyl)-4-methoxybenzaldehyde manufacturer Compared with individuals with cancer only, those with ASCVD and with ASCVD and cancer had a significantly higher presence of three of more of these factors (23 and 30 percent, respectively, versus 13 percent). 3-(tert-Butyl)-4-methoxybenzaldehyde supplier As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials. 3-(tert-Butyl)-4-methoxybenzaldehyde vendor In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. . 3-(tert-Butyl)-4-methoxybenzaldehyde factory Compared with individuals with cancer only, those with ASCVD and with ASCVD and cancer had a significantly higher presence of three of more of these factors (23 and 30 percent, respectively, versus 13 percent).